HIV-1 Genotype Resistance Testing Kits and Reagents

The U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of Walter Reed Army Institute of Research (WRAIR) intends to negotiate solely (as prescribed in FAR 13.106(b)(1)(i)) with ABBOTT MOLECULAR INC., 1300 E TOUHY AVE, DES PLAINES IL 60018-3315, for the procurement of Reagents, Consumables, and Software Upgrade for HIV-1 Genotype Resistance Testing. Specifically, the government will establish a Blanket Purchase Agreement (BPA) to purchase the following items:

Product List Number Product Description
04J94-091 ViroSeq HIV-1 v2 Genotype System Kit, IVD
04J94-092 Sequencing Consumables Pack
04J94-073 PCR Cleanup Kit
04J94-71 VS HIV-1 Integrase GT Kit, RUO
04J94-72 VS HIV-1 Sam Prep Ki

This requirement is for Kits and Reagents for HIV-1 Genotype Resistance Testing using a FDA-approved kit for the protease/reverse transcriptase genes of HIV-1, an HIV-1 Integrase Genotype kit having a Research Use Only (RUO) designation and validated software for analysis/report generation

The North American Industry Classification System (NAICS) for this requirement is 325413 and the size standard is 1,250 Employees.

This announcement constitutes the only notice by the government; a written solicitation will not be issued. All sources that believe they are eligible to provide these items must respond in writing. Responses must be supported with clear and convincing evidence to clearly articulate the ability to provide the items outlined above. A request for documentation will not be considered an affirmative response. This Special Notice of Intent is not a request for competitive quotes. Information received will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. If no written responses are received by the date listed below, the purchase will be awarded without further remark. All questions and responses concerning this notice shall be emailed to Ms. Dawn Jennings at dawn.v.jennings.civ@mail.mil.

Interested concerns must identify their capability in writing to the above e-mail address or by mail to the address listed below no later than12:00 pm EST, Tuesday, 14 May, 2019.

Contracting Office Address:
US Army Medical Research Acquisition Activity, ATTN: MCMR-AAA-MB, 820 Chandler Street, Frederick, MD 21702-5014

Point of Contact:
Dawn Jennings

.